Contract Manufacturing, General

Chime Biologics to Manufacture Novel Antibody Cancer Immunotherapy for Domain Therapeutics

March 14, 2024

In a new manufacturing pact, Chime Biologics will produce DT-7012, Domain Therapeutics' antibody candidate for treating cancer that will soon be entering Phase I studies.

Cellares Set to Launch Good Manufacturing Practice–Compliant Cell Shuttle Manufacturing Platform

March 12, 2024

The Cell Shuttle platform will manufacture cell therapies for its first clinical trials by the end of the year.

Cellares Innovates With Automated Cell and Gene Therapy Platform

March 07, 2024

Cellares CEO Fabian Gerlinghaus shares how an automated, closed-production platform with a small footprint can dramatically impact cost savings and scalability for cell and gene therapies.

CordenPharma Expands Clinical Peptide Capacity

March 06, 2024

The company is expanding GMP capacities at its Frankfurt site to manufacture early clinical-phase peptide APIs.

Simtra BioPharma Solutions Expands Sterile Fill/Finish Manufacturing Site

February 28, 2024

The company is investing more than $250 million into its Bloomington, Ind. Manufacturing site.

CSL Licenses Cytegrity Lentiviral Vector Production System to Genezen

February 27, 2024

CSL will share access to Cytegrity, its proprietary stable production system for lentiviral vector production, with Genezen.

Managing the Complexity of Modern Sterile Product Developments

February 16, 2024

Managing the intricacies of sterile product development is imperative for successful and compliant outcomes.

Ensuring Quality in Contracted Support

February 15, 2024

This article looks at the relationship between a CDMO quality organization and the client.

How to Evaluate a CDMO’s Commitment to Quality

February 15, 2024

What do you need to ask during the vetting and selection process to ensure your clinical or commercial program won’t be derailed by a quality-related problem?

Nelson Labs Creates Center of Excellence for Parenteral and Ophthalmic Drug Manufacturing

February 15, 2024

The company’s Itasca, Ill., facility will offer chemistry, manufacturing, and controls analytical testing support.